Late preterm birth has direct and indirect effects on infant gut microbiota development during the first six months of life.
OBJECTIVE
Preterm infants display aberrant gut microbial colonisation. We investigated whether the differences in gut microbiota between late preterm and full-term infants results from prematurity or external exposures.


METHODS
This study comprised 43 late preterm infants (340/7-366/7) and 75 full-term infants based on faecal samples collected following birth and at two to four weeks and six months of age. We assessed clinically relevant bacteria using quantitative polymerase chain reaction. Logistic regression analyses were performed to determine whether the observed differences in gut microbiota were attributable to prematurity or perinatal exposure.


RESULTS
The prevalence of bifidobacteria differed in the intestinal microbiota of the full-term and late preterm neonates. Differences in the presence of specific species were detected at the age of six months, although the microbiota alterations were most prominent following delivery. As well as prematurity, the mode of birth, intrapartum and neonatal antibiotic exposure, and the duration of breastfeeding had an additional impact on gut microbiota development.


CONCLUSIONS
The gut microbiota composition was significantly different between late preterm and full-term infants at least six months after birth. Antibiotic exposure was common in late preterm infants and modulated gut colonisation, but preterm birth also affected gut microbiota development independently.
Department of Paediatrics, University of Turku, Turku, Finland.
M
M
Forsgren
Department of Paediatrics, University of Turku, Turku, Finland.|Department of Paediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland.
E
E
Isolauri
Functional Foods Forum, University of Turku, Turku, Finland.
S
S
Salminen
Department of Paediatrics, University of Turku, Turku, Finland.|Department of Paediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland.
S
S
Rautava
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D005260:Female; D000069196:Gastrointestinal Microbiome / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D011247:Pregnancy; D055815:Young Adult
D000900:Anti-Bacterial Agents
Antibiotics; Caesarean section; Gut colonisation; Intestinal microbiota; Late preterm neonate